<DOC>
	<DOCNO>NCT02613013</DOCNO>
	<brief_summary>This 10-centre randomized control clinical trial explore whether laser peripheral iridoplasty ( LPIP ) plus laser peripheral iridotomy ( LPI ) effective single LPI control progression primary angle closure multi-mechanism base UBM classification .</brief_summary>
	<brief_title>Laser Peripheral Iridotomy Plus Laser Peripheral Iridoplasty Primary Angle Closure</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma , Angle-Closure</mesh_term>
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Proxymetacaine</mesh_term>
	<mesh_term>Propoxycaine</mesh_term>
	<mesh_term>Pilocarpine</mesh_term>
	<criteria>1 . Clinical diagnosis primary angle closure ( PAC ) , IOP≤30mmHg PAS≤270° . 2 . PAC multimechanism base UBM examination ( multimechanism define primary angle closure cause pupil block plus least one kind nonpupil block factor like ( relative anterior position thick ciliary body , big volume iris , anterior location iris insertion ciliary body ) two kind combination . 3 . Visual acuity≥ 20/40 4 . Age 4075 year old Chinese people If eyes patient eligible study , e eye bad visual acuity select . Only one eye per patient eligible study . Drug washout : Eligible patient already antiglaucoma medication require drug washout randomize . Various medication different washout period : Prostaglandin analogues 4 week , Beta blocker 3 week , Adrenergic agonist 2 week , Cholinergic agonist 5 day , Carbonic Anhydrase Inhibitors 5 day . Patients whose IOP &gt; 30 mm Hg washout period stop washout withdrawn study . 1 . Unwilling unable give consent , unwilling accept randomization , unable return schedule protocol visit . 2 . Angle closure due secondary cause ( subluxed lens , neovascular , uveitic , traumatic , postoperative ) 3 . Previous incisional intraocular surgery ocular laser study eye ( LPI LPIP , cyclodestructive procedure , cataract surgery ) 4 . Primary angle closure glaucomatous neuropathy . 5 . Have cataract study eye anticipate cataract surgery come 3 year ; exist cataract affect visual field examination fundus examination ; visual acuity &lt; 20/40 due exist cataract . 6. Who use IOP low drug drug washout 7 . Need glaucoma surgery combine ocular procedure ( i.e . cataract surgery , penetrate keratoplasty , retinal surgery ) anticipate need urgent additional ocular surgery 8 . Coexisting ocular disease ( i.e . cornea abnormal cornea infection , Iridocorneal endothelial syndrome anterior segment dysgenesis , nanophthalmos , high myopia ( &gt; 6.0D ) , Chronic recurrent uveitis , ocular cancer , trauma , central retinal vein occlusion , central retinal artery occlusion , retinal detachment ) 9. cornea endothelium count &lt; 1000/mm2 10. need local systemic steroid longterm use 11 . Unwilling discontinue contact lens use surgery 12. Who take part drug clinical trial 13 . Pregnant nursing woman 14 . Severe systemic disease ( i.e . diabetes mellitus , hypertension , end stage cardiac disease , nephropathy disease , respiratory disease cancer . 15 . Allergic pilocarpine alcaine 16 . Contraindication ocular laser disease .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>